The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

First spotted last month by a telescope in Chile, the near-Earth asteroid — designated 2024 YR4 — is estimated to be 130 to ...